Literature DB >> 14769943

Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families.

Danielle M Friedrichsen1, Janet L Stanford, Sarah D Isaacs, Marta Janer, Bao-Li Chang, Kerry Deutsch, Elizabeth Gillanders, Suzanne Kolb, Katherine E Wiley, Michael D Badzioch, S Lilly Zheng, Patrick C Walsh, Gail P Jarvik, Leroy Hood, Jeffrey M Trent, William B Isaacs, Elaine A Ostrander, Jianfeng Xu.   

Abstract

Results from over a dozen prostate cancer susceptibility genome-wide scans, encompassing some 1,500 hereditary prostate cancer families, indicate that prostate cancer is an extremely heterogeneous disease with multiple loci contributing to overall susceptibility. In an attempt to reduce locus heterogeneity, we performed a genomewide linkage scan for prostate cancer susceptibility genes with 36 Jewish families, which represent a stratification of hereditary prostate cancer families with potentially increased locus homogeneity. The 36 Jewish families represent a combined dataset of 17 Jewish families from the Fred Hutchinson Cancer Research Center-based Prostate Cancer Genetic Research Study dataset and 19 Ashkenazi Jewish families collected at Johns Hopkins University. All available family members, including 94 affected men, were genotyped at markers distributed across the genome with an average interval of <10 centimorgans. Nonparametric multipoint linkage analyses were the primary approach, although parametric analyses were performed as well. Our strongest signal was a significant linkage peak at 7q11-21, with a nonparametric linkage (NPL) score of 3.01 (P = 0.0013). Simulations indicated that this corresponds to a genomewide empirical P = 0.006. All other regions had NPL P values >/=0.02. After genotyping additional markers within the 7q11-21 peak, the NPL score increased to 3.35 (P = 0.0004) at D7S634 with an allele-sharing logarithm of odds of 3.12 (P = 0.00007). These studies highlight the utility of analyzing defined sets of families with a common origin for reducing locus heterogeneity problems associated with studying complex traits.

Entities:  

Mesh:

Year:  2004        PMID: 14769943      PMCID: PMC357031          DOI: 10.1073/pnas.0308336100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  69 in total

1.  A genomic scan of families with prostate cancer identifies multiple regions of interest.

Authors:  M Gibbs; J L Stanford; G P Jarvik; M Janer; M Badzioch; M A Peters; E L Goode; S Kolb; L Chakrabarti; M Shook; R Basom; E A Ostrander; L Hood
Journal:  Am J Hum Genet       Date:  2000-05-19       Impact factor: 11.025

2.  Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families.

Authors:  Jianfeng Xu; Elizabeth M Gillanders; Sarah D Isaacs; Bao-Li Chang; Kathy E Wiley; S Lilly Zheng; MaryPat Jones; Derek Gildea; Erica Riedesel; Julie Albertus; Diana Freas-Lutz; Carol Markey; Deborah A Meyers; Patrick C Walsh; Jeffrey M Trent; William B Isaacs
Journal:  Prostate       Date:  2003-12-01       Impact factor: 4.104

3.  Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX.

Authors:  E M Lange; H Chen; K Brierley; E E Perrone; C H Bock; E Gillanders; M E Ray; K A Cooney
Journal:  Clin Cancer Res       Date:  1999-12       Impact factor: 12.531

4.  Parametric and nonparametric linkage analysis: a unified multipoint approach.

Authors:  L Kruglyak; M J Daly; M P Reeve-Daly; E S Lander
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

5.  HPC2 variants and screen-detected prostate cancer.

Authors:  D Vesprini; R K Nam; J Trachtenberg; M A Jewett; S V Tavtigian; M Emami; M Ho; A Toi; S A Narod
Journal:  Am J Hum Genet       Date:  2001-03-14       Impact factor: 11.025

6.  Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics.

Authors:  J Xu
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

7.  Linkage analysis of 150 high-risk prostate cancer families at 1q24-25.

Authors:  E L Goode; J L Stanford; L Chakrabarti; M Gibbs; S Kolb; R A McIndoe; V A Buckley; E F Schuster; C L Neal; E L Miller; S Brandzel; L Hood; E A Ostrander; G P Jarvik
Journal:  Genet Epidemiol       Date:  2000-03       Impact factor: 2.135

8.  A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews.

Authors:  Hanna Rennert; Dani Bercovich; Ayala Hubert; Dvora Abeliovich; Uri Rozovsky; Anat Bar-Shira; Sonya Soloviov; Letizia Schreiber; Haim Matzkin; Gad Rennert; Luna Kadouri; Tamar Peretz; Yuval Yaron; Avi Orr-Urtreger
Journal:  Am J Hum Genet       Date:  2002-07-23       Impact factor: 11.025

9.  The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.

Authors:  J P Struewing; D Abeliovich; T Peretz; N Avishai; M M Kaback; F S Collins; L C Brody
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

10.  High risk genes predisposing to prostate cancer development-do they exist?

Authors:  R Singh; R A Eeles; F Durocher; J Simard; S Edwards; M Badzioch; Z Kote-Jarai; D Teare; D Ford; D Dearnaley; A Ardern-Jones; A Murkin; A Dowe; R Shearer; J Kelly; F Labrie; D Easton; S A Narod; P N Tonin; W D Foulkes
Journal:  Prostate Cancer Prostatic Dis       Date:  2000-12       Impact factor: 5.554

View more
  8 in total

1.  A recessive gene for primary vesicoureteral reflux maps to chromosome 12p11-q13.

Authors:  Patricia L Weng; Simone Sanna-Cherchi; Terry Hensle; Ellen Shapiro; Alan Werzberger; Gianluca Caridi; Claudia Izzi; Anita Konka; Adam C Reese; Rong Cheng; Samuel Werzberger; Richard N Schlussel; Robert D Burk; Joseph H Lee; Roberto Ravazzolo; Francesco Scolari; Gian Marco Ghiggeri; Kenneth Glassberg; Ali G Gharavi
Journal:  J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 10.121

Review 2.  Prostate cancer susceptibility loci: finding the genes.

Authors:  Elanie A Ostrander; Bo Johannesson
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

3.  Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer.

Authors:  Marc D Tischkowitz; Ahmet Yilmaz; Long Q Chen; Danielle M Karyadi; David Novak; Tomas Kirchhoff; Nancy Hamel; Sean V Tavtigian; Suzanne Kolb; Tarek A Bismar; Raquel Aloyz; Peter S Nelson; Lee Hood; Steven A Narod; Kirsten A White; Elaine A Ostrander; William B Isaacs; Kenneth Offit; Kathleen A Cooney; Janet L Stanford; William D Foulkes
Journal:  Cancer Lett       Date:  2008-06-20       Impact factor: 8.679

4.  Prostate cancer risk-associated genetic markers and their potential clinical utility.

Authors:  Jianfeng Xu; Jielin Sun; S Lilly Zheng
Journal:  Asian J Androl       Date:  2013-04-08       Impact factor: 3.285

5.  Dense genome-wide SNP linkage scan in 301 hereditary prostate cancer families identifies multiple regions with suggestive evidence for linkage.

Authors:  Janet L Stanford; Liesel M FitzGerald; Shannon K McDonnell; Erin E Carlson; Laura M McIntosh; Kerry Deutsch; Lee Hood; Elaine A Ostrander; Daniel J Schaid
Journal:  Hum Mol Genet       Date:  2009-02-27       Impact factor: 6.150

6.  Lipoprotein genotype and conserved pathway for exceptional longevity in humans.

Authors:  Gil Atzmon; Marielisa Rincon; Clyde B Schechter; Alan R Shuldiner; Richard B Lipton; Aviv Bergman; Nir Barzilai
Journal:  PLoS Biol       Date:  2006-04-04       Impact factor: 8.029

7.  Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families.

Authors:  Joan E Bailey-Wilson; Erica J Childs; Cheryl D Cropp; Daniel J Schaid; Jianfeng Xu; Nicola J Camp; Lisa A Cannon-Albright; James M Farnham; Asha George; Isaac Powell; John D Carpten; Graham G Giles; John L Hopper; Gianluca Severi; Dallas R English; William D Foulkes; Lovise Mæhle; Pål Møller; Rosalind Eeles; Douglas Easton; Michelle Guy; Steve Edwards; Michael D Badzioch; Alice S Whittemore; Ingrid Oakley-Girvan; Chih-Lin Hsieh; Latchezar Dimitrov; Janet L Stanford; Danielle M Karyadi; Kerry Deutsch; Laura McIntosh; Elaine A Ostrander; Kathleen E Wiley; Sarah D Isaacs; Patrick C Walsh; Stephen N Thibodeau; Shannon K McDonnell; Scott Hebbring; Ethan M Lange; Kathleen A Cooney; Teuvo L J Tammela; Johanna Schleutker; Christiane Maier; Sylvia Bochum; Josef Hoegel; Henrik Grönberg; Fredrik Wiklund; Monica Emanuelsson; Geraldine Cancel-Tassin; Antoine Valeri; Olivier Cussenot; William B Isaacs
Journal:  BMC Med Genet       Date:  2012-06-19       Impact factor: 2.103

8.  Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients.

Authors:  Bente A Talseth-Palmer; Elizabeth G Holliday; Tiffany-Jane Evans; Mark McEvoy; John Attia; Desma M Grice; Amy L Masson; Cliff Meldrum; Allan Spigelman; Rodney J Scott
Journal:  BMC Med Genomics       Date:  2013-03-26       Impact factor: 3.063

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.